Common Stock, Shares, Outstanding of Co-Diagnostics, Inc. from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Co-Diagnostics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2016 to 30 Sep 2025.
  • Co-Diagnostics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 48,142,582, a 51% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Co-Diagnostics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 48,142,582 +16,212,830 +51% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 36,182,468 +4,271,466 +13% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 33,572,643 +2,294,225 +7.3% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 33,053,544 +1,793,876 +5.7% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 31,929,752 +1,271,172 +4.1% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 31,911,002 +1,122,131 +3.6% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 31,278,418 +646,073 +2.1% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 31,259,668 +387,061 +1.3% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 30,658,580 -259,276 -0.84% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 30,788,871 -2,992,121 -8.9% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 30,632,345 -3,351,723 -9.9% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 30,872,607 -2,947,255 -8.7% 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 30,917,856 +2,022,966 +7% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 33,780,992 +4,891,102 +17% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 33,984,068 +5,318,354 +19% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 33,819,862 +5,261,829 +18% 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 28,894,890 +733,631 +2.6% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 28,889,890 +898,848 +3.2% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 28,665,714 +1,214,650 +4.4% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 28,558,033 +11,215,111 +65% 31 Dec 2020 10-K 24 Mar 2022 2021 FY
Q3 2020 28,161,259 +10,824,337 +62% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 27,991,042 +10,875,276 +64% 30 Jun 2020 10-Q/A 03 Nov 2020 2020 Q2
Q1 2020 27,451,064 +10,435,298 +61% 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 17,342,922 +4,419,539 +34% 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q3 2019 17,336,922 +4,671,899 +37% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 17,115,766 +4,767,739 +39% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 17,015,766 +4,689,357 +38% 31 Mar 2019 10-Q 14 May 2019 2019 Q1
Q4 2018 12,923,383 +606,199 +4.9% 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q3 2018 12,665,023 +382,048 +3.1% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 12,348,027 +2,465,843 +25% 30 Jun 2018 10-Q 10 Aug 2018 2018 Q2
Q1 2018 12,326,409 31 Mar 2018 10-Q 14 May 2018 2018 Q1
Q4 2017 12,317,184 +2,434,789 +25% 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q3 2017 12,282,975 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 9,882,184 30 Jun 2017 10-Q 25 Aug 2017 2017 Q2
Q4 2016 9,882,395 31 Dec 2016 10-K 28 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.